Projected Income Statement: CME Group Inc.

Forecast Balance Sheet: CME Group Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 610 718 402 422 -1,120 -314 -231 -409
Change - 17.7% -44.01% 4.98% -365.4% 71.95% 26.43% -77.06%
Announcement Date 09/02/22 08/02/23 14/02/24 12/02/25 04/02/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: CME Group Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 127.2 89.7 76.4 94 83.5 86.08 93.28 98
Change - -29.48% -14.83% 23.04% -11.17% 3.09% 8.37% 5.05%
Free Cash Flow (FCF) 1 2,275 2,966 3,377 3,596 4,194 4,161 4,711 4,930
Change - 30.38% 13.86% 6.49% 16.6% -0.78% 13.22% 4.66%
Announcement Date 09/02/22 08/02/23 14/02/24 12/02/25 04/02/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: CME Group Inc.

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 66.69% 67.31% 67.86% 70.12% 71.04% 73.47% 73.12% 74.7%
EBIT Margin (%) 63.58% 64.62% 65.61% 68.26% 69.39% 70.03% 70.46% 73.27%
EBT Margin (%) 71.94% 69.54% 74.45% 74.08% 81.75% 79.22% 81.32% 81.2%
Net margin (%) 56.22% 52.94% 57.1% 56.79% 61.67% 59.72% 56.49% 55.33%
FCF margin (%) 48.51% 59.1% 60.54% 58.67% 64.31% 59.78% 64.85% 63.37%
FCF / Net Income (%) 86.3% 111.63% 106.02% 103.3% 104.29% 100.1% 114.79% 114.53%

Profitability

        
ROA 1.64% 1.54% 2.1% 2.76% 2.4% 2.16% 2.34% 2.6%
ROE 9.82% 10.55% 11.88% 13.87% 14.62% 15.35% 15.69% 15.93%

Financial Health

        
Leverage (Debt/EBITDA) 0.2x 0.21x 0.11x 0.1x - - - -
Debt / Free cash flow 0.27x 0.24x 0.12x 0.12x - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 2.71% 1.79% 1.37% 1.53% 1.28% 1.24% 1.28% 1.26%
CAPEX / EBITDA (%) 4.07% 2.66% 2.02% 2.19% 1.8% 1.68% 1.76% 1.69%
CAPEX / FCF (%) 5.59% 3.02% 2.26% 2.61% 1.99% 2.07% 1.98% 1.99%

Items per share

        
Cash flow per share 1 6.693 8.508 - - - - - -
Change - 27.12% - - - - - -
Dividend per Share 1 6.85 8.5 9.65 12 5 11.81 11.51 12.5
Change - 24.09% 13.53% 24.35% -58.33% 136.25% -2.59% 8.61%
Book Value Per Share 1 76.41 74.89 74.38 73.59 80.03 78.78 87.36 104.5
Change - -1.99% -0.68% -1.06% 8.76% -1.57% 10.89% 19.65%
EPS 1 7.29 7.4 8.86 9.67 11.16 11.79 12.13 12.9
Change - 1.51% 19.73% 9.14% 15.41% 5.69% 2.86% 6.3%
Nbr of stocks (in thousands) 3,59,399 3,59,728 3,59,993 3,60,362 3,60,600 3,58,625 3,58,625 3,58,625
Announcement Date 09/02/22 08/02/23 14/02/24 12/02/25 04/02/26 - - -
1USD
Estimates
2026 *2027 *
P/E ratio 26.4x 25.7x
PBR 3.95x 3.56x
EV / Sales 16x 15.3x
Yield 3.79% 3.69%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
311.40USD
Average target price
306.21USD
Spread / Average Target
-1.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. CME Stock
  4. Financials CME Group Inc.
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW